Skip to content

Releases: brunomontezano/randomizacao-shiny

Clinical Trial Randomization Tool (PT-BR)

14 Apr 15:39
Compare
Choose a tag to compare

I'm excited to introduce the "Ferramenta para randomização em ensaios clínicos" (Clinical Trial Randomization Tool) repository, a robust solution meticulously crafted for the generation of randomization tables in clinical trials. Developed using R and Shiny, this project offers a user-friendly interface accessible via shinyapps.io. The tool is currently deployed in Brazilian Portuguese.

Overview:
This web application generates two essential tables for clinical trials: a randomization table and a table to unveil initially blinded treatment arms. By leveraging R's and set.seed functions, the tool ensures both randomness and replicability in the randomization process, facilitating robust research outcomes.

Key Features:

  • Randomization table generation: Seamlessly generate randomization tables to allocate participants to treatment arms in clinical trials.
  • Reproducibility: Utilize R's set.seed function to ensure replicability, enabling researchers to reproduce results consistently.
  • Data export: Easily download generated tables in CSV format for local analysis and record-keeping purposes.

Acknowledgments:
This project draws inspiration from a similar initiative by the author aurora-mareviv, underscoring the collaborative spirit of the scientific community.

License:
The repository is licensed under GPL-3, fostering openness and accessibility. Please refer to the LICENSE file for the full license details.

For International Users:
Designed with simplicity and efficiency in mind, this tool caters to researchers worldwide, facilitating randomized allocation in clinical trials with ease and reliability. Unfortunately, the tool is currently avaiable only in Brazilian Portuguese.

We invite you to explore the "Ferramenta para randomização em ensaios clínicos" repository, contribute to its development, and leverage its capabilities to enhance the rigor and efficiency of clinical research endeavors.

Thank you for your interest and support.